Carcinogenesis, Vol. 20, No. 12, 2195-2208,
December 1999
© 1999 Oxford University Press
Review |
Molecular epidemiology, pathogenesis and prevention of gastric cancer
Department of Epidemiology and International Health, University of Alabama at Birmingham, School of Public Health, 220F Ryals Building, 1665 University Boulevard, Birmingham, AL 35294-0022, USA
Cancer of the stomach is one of the most commonly diagnosed malignancies and remains an important cause of mortality world wide. This type of cancer is not uniformly distributed among populations but shows a marked variation in both incidence and mortality. Although gastric cancer is declining in many parts of the world, the reasons for this decline are not well understood and its etiology remains unclear. Several factors are suspected to play a role in gastric carcinogenesis, including the effects of diet, exogenous chemicals, intragastric synthesis of carcinogens, genetic factors, infectious agents and pathological conditions in the stomach (such as gastritis). A new look at the results of epidemiological and experimental studies is important for the establishment of strategies for control. Since cancer of the stomach has a very poor prognosis in its more advanced stages, such a control program must have its main focus on primary prevention. This review describes our knowledge about cancer of the stomach regarding epidemiology, pathogenesis and prevention.
Abbreviations: CI, confidence interval; EB, Epstein–Barr; IgA, immunoglobulin A; LOH, loss of heterozygosity; MALT, mucosa-associated lymphoid tissue; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; MNU, N-methyl-N-nitrosourea; NOC, N-nitroso compounds; OR, odds ratio; PG I, pepsinogen I.
1 To whom correspondence should be addressed Email: h2obor{at}uab.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Y. Shin, W. K. K. Wu, K. M. Chu, M. W. L. Koo, H. P. S. Wong, E. K. Y. Lam, E. K. K. Tai, and C. H. Cho Functional Role of {beta}-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells Toxicol. Sci., March 1, 2007; 96(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gottschalg, G. B. Scott, P. A. Burns, and D. E.G. Shuker Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer Carcinogenesis, February 1, 2007; 28(2): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tajima, K. Yamazaki, R. Makino, N. Nishino, S. Aoki, M. Kato, K. Morohara, T. Kaetsu, and M. Kusano Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin. Cancer Res., November 1, 2006; 12(21): 6469 - 6479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Savage, L. Hou, J. Lissowska, W.-H. Chow, W. Zatonski, S. J. Chanock, and M. Yeager Interleukin-8 polymorphisms are not associated with gastric cancer risk in a polish population. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 589 - 591. [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Sun, Y. L. Sun, R. N. Fang, Y. Shao, H. C. Xu, Q. P. Xue, G. X. Ding, and Y. L. Cheng Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and its Correlation with Angiogenesis Jpn. J. Clin. Oncol., December 1, 2005; 35(12): 707 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Y. Shin, W. K.K. Wu, K.-M. Chu, H. P.S. Wong, E. K.Y. Lam, E. K.K. Tai, M. W.L. Koo, and C.-H. Cho Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric Cancer Mol. Cancer Res., November 1, 2005; 3(11): 607 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Huang, W.-H. Chow, N. Rothman, J. Lissowska, V. Llaca, M. Yeager, W. Zatonski, and R. B. Hayes Selected DNA repair polymorphisms and gastric cancer in Poland Carcinogenesis, August 1, 2005; 26(8): 1354 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Watabe, T Mitsushima, Y Yamaji, M Okamoto, R Wada, T Kokubo, H Doi, H Yoshida, T Kawabe, and M Omata Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Gut, June 1, 2005; 54(6): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Malta-Vacas, C Aires, P Costa, A R Conde, S Ramos, A P Martins, C Monteiro, and M Brito Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types J. Clin. Pathol., June 1, 2005; 58(6): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Variants of the IL8 and IL8RB Genes and Risk for Gastric Cardia Adenocarcinoma and Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Okano, H. Shinohara, A. Miyamoto, K. Takaori, and N. Tanigawa Concomitant Overexpression of Cyclooxygenase-2 in HER-2-Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome Clin. Cancer Res., October 15, 2004; 10(20): 6938 - 6945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Meireles, E. B. Cristo, A. F. Carvalho, R. Hirata Jr., A. Pelosof, L. I. Gomes, W. K. Martins, M. D. Begnami, C. Zitron, A. L. Montagnini, et al. Molecular Classifiers for Gastric Cancer and Nonmalignant Diseases of the Gastric Mucosa Cancer Res., February 15, 2004; 64(4): 1255 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-W. Zhang, P. Newcomb, A. Hollowood, R. Feakins, M. Moorghen, A. Storey, M. J. G. Farthing, D. Alderson, and J. Holly Age-associated Increase of Codon 72 Arginine p53 Frequency in Gastric Cardia and Non-Cardia Adenocarcinoma Clin. Cancer Res., June 1, 2003; 9(6): 2151 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inoue, A. Matsuyama, K. Mimori, H. Ueo, and M. Mori Prognostic Score of Gastric Cancer Determined by cDNA Microarray Clin. Cancer Res., November 1, 2002; 8(11): 3475 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. van Rees, E. Caspers, A. zur Hausen, A. van den Brule, P. Drillenburg, M. A. J. Weterman, and G. J. A. Offerhaus Different Pattern of Allelic Loss in Epstein-Barr Virus-Positive Gastric Cancer with Emphasis on the p53 Tumor Suppressor Pathway Am. J. Pathol., October 1, 2002; 161(4): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Lee, S. C. Abraham, H.-S. Kim, J.-H. Nam, C. Choi, M.-C. Lee, C.-S. Park, S.-W. Juhng, A. Rashid, S. R. Hamilton, et al. Inverse Relationship between APC Gene Mutation in Gastric Adenomas and Development of Adenocarcinoma Am. J. Pathol., August 1, 2002; 161(2): 611 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andersson, J. McGuire, C. Rubio, K. Gradin, M. L. Whitelaw, S. Pettersson, A. Hanberg, and L. Poellinger A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors PNAS, July 23, 2002; 99(15): 9990 - 9995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Saukkonen, O. Nieminen, B. van Rees, S. Vilkki, M. Harkonen, M. Juhola, J.-P. Mecklin, P. Sipponen, and A. Ristimaki Expression of Cyclooxygenase-2 in Dysplasia of the Stomach and in Intestinal-type Gastric Adenocarcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1923 - 1931. [Abstract] [Full Text] [PDF]
|
|